European Trainer - Issue 46 - Summer 2014

Page 66

FLU TRAINER ISSUE 46_Jerkins feature.qxd 30/06/2014 21:22 Page 1

VETERINARY

INFLUENZA Are we protecting our horses effectively?

The devastating flu outbreak that rampaged through the Australian horse population in 2007 was an important wake-up call reminding us that the equine influenza virus is an ever-present threat. In Europe and America, the economic losses and welfare impact of flu are minimised by vaccination, but still occasional outbreaks continue to occur. WORDS: PROFESSOR CElia M MaRR, EDitOR, EquinE VEtERinaRy JOuRnal, nEWMaRkEt, SuFFOlk, uk PHOtOS: SHuttERStOCk, CaROlinE nORRiS, PROFESSOR CElia M MaRR

How do the flu vaccines work? Vaccination stimulates the horse’s immune system to produce antibodies. These equine proteins recognise antigens, specific proteins on the surface of the virus. The antibody and antigen fit together, rather like a lock and key,

to prevent the virus from entering the cells in the horse’s respiratory tract. Not only do these antibodies persist in the horse but the vaccine also stimulates an immunological memory. When the vaccinated horse meets the flu virus again, the immune

Equine Veterinary Journal (EVJ) recently published a series of articles focussing on equine influenza offering views from virologists, drug regulators, sporting authorities and the animal health industry. In addition, flu researchers from the Irish Equine Centre in Kildare have shared important insights from their work on flu control in two recent research articles published in EVJ.

system recognises the antigens as similar to the vaccine and quickly mounts a protective response to attack the invading virus.

Virus strains Flu virus strains are named after two antigens on their surface, haemagglutinin (HA) and neuraminidase. HA is responsible for entry into equine cells lining the respiratory tract while the neuraminidase is involved in virus replication. The equine flu viruses all belong to the H3N8 family. Humans are affected by flu viruses of other strains, but equine influenza poses no threat. Groups of viruses of closely related strains are called Clades and currently there are two Clades of equine influenza viruses circulating globally.

Constant evasive action by the flu virus

The flu vaccine stimulates the horse to produce antibodies that recognise the haemagglutinin proteins on the virus surface, represented here in green. These proteins are important for the process by which the virus gains entry to the horse’s cells. Antibodies against HA prevent the virus attaching to the respiratory tract and protect against infection. As the HA proteins mutate, they are less easily recognised by antibodies produced in response to outdated vaccines and vaccines containing old virus strains becomes less effective. (Diagram from Professor Paul Digard, The Roslin Institute, University of Edinburgh, EVJ DOI: 10.1111/evj.12148) 64 TRAINERMAGAZINE.com ISSUE 46

Equine flu vaccines are all targeted at the HA protein. But the flu virus is smart, and through a process called antigenic drift, it is continuously mutating and changing the genes that code for the HA antigenic site. As these changes occur, the vaccine becomes ever less effective.

What’s the point in vaccination?

Flu causes nasal discharge, coughing, and fever. Vaccination can reduce the prevalence, severity and duration of these signs. (Photo courtesey of Richard Payne, Rossdales Equine Hospital, Newmarket)

When an unvaccinated horse is infected with flu, first the virus invades the nasal passages and at this early stage, the horse begins to shed large amounts of virus and is highly contagious to other horses. Then, the horse develops clinical signs such as coughing, nasal discharge, and fever. An EVJ study from French researcher Dr


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.